Literature DB >> 14761106

What's a man to do? Treatment options for localized prostate cancer.

Tom Pickles1.   

Abstract

OBJECTIVE: To describe treatments for localized prostate cancer: surgery, external radiation therapy, and brachytherapy; watchful waiting might also be appropriate. Patients trying to decide about treatment ask family physicians for advice. This article sets out a framework to aid patients (and physicians) in the decision. QUALITY OF EVIDENCE: Only two randomized studies comparing different treatments were identified. Because of the paucity of level I or II evidence, suggestions in this review are largely based on expert opinion and consensus statements. MAIN MESSAGE Risk-grouping and nomograms are useful for assessing treatments and estimating outcomes of treatment. Where treatments are equivalent, decisions can be based on perception of toxicity and convenience. Effects on patients'lives and on sexual, urinary, and bowel function vary by treatment modality.
CONCLUSION: Men with low-risk prostate cancer should decide on treatment based on their perception of how treatment will affect their lives. Men with higher-risk cancers might accept adverse effects on their quality of life in return for longer survival.

Entities:  

Mesh:

Year:  2004        PMID: 14761106      PMCID: PMC2214501     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  32 in total

Review 1.  Three-dimensional conformal radiotherapy and dose escalation: where do we stand?

Authors:  M J Zelefsky; S A Leibel; G J Kutcher; Z Fuks
Journal:  Semin Radiat Oncol       Date:  1998-04       Impact factor: 5.934

2.  Comparison of perspectives on prostate cancer: analyses of survey data.

Authors:  E D Crawford; C L Bennett; N N Stone; S J Knight; E DeAntoni; L Sharp; M B Garnick; H A Porterfield
Journal:  Urology       Date:  1997-09       Impact factor: 2.649

3.  Differences in urologist and patient assessments of health related quality of life in men with prostate cancer: results of the CaPSURE database.

Authors:  M S Litwin; D P Lubeck; J M Henning; P R Carroll
Journal:  J Urol       Date:  1998-06       Impact factor: 7.450

4.  Temporal trends in radical prostatectomy complications from 1991 to 1998.

Authors:  Jim C Hu; Karen F Gold; Chris L Pashos; Shilpa S Mehta; Mark S Litwin
Journal:  J Urol       Date:  2003-04       Impact factor: 7.450

5.  Watchful waiting or watchful progression?: Prostate specific antigen doubling times and clinical behavior in patients with early untreated prostate carcinoma.

Authors:  D B McLaren; M McKenzie; G Duncan; T Pickles
Journal:  Cancer       Date:  1998-01-15       Impact factor: 6.860

6.  Quality of life after radical prostatectomy or watchful waiting.

Authors:  Gunnar Steineck; Fred Helgesen; Jan Adolfsson; Paul W Dickman; Jan-Erik Johansson; Bo Johan Norlén; Lars Holmberg
Journal:  N Engl J Med       Date:  2002-09-12       Impact factor: 91.245

7.  Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer.

Authors:  P C Albertsen; J A Hanley; D F Gleason; M J Barry
Journal:  JAMA       Date:  1998-09-16       Impact factor: 56.272

8.  Role of surgeon volume in radical prostatectomy outcomes.

Authors:  Jim C Hu; Karen F Gold; Chris L Pashos; Shilpa S Mehta; Mark S Litwin
Journal:  J Clin Oncol       Date:  2003-02-01       Impact factor: 44.544

9.  Patterns of positive specimen margins and detectable prostate specific antigen after radical perineal prostatectomy.

Authors:  V E Weldon; F R Tavel; H Neuwirth; R Cohen
Journal:  J Urol       Date:  1995-05       Impact factor: 7.450

Review 10.  Prediction of progression: nomograms of clinical utility.

Authors:  Michael W Kattan; Peter T Scardino
Journal:  Clin Prostate Cancer       Date:  2002-09
View more
  2 in total

1.  Helping patients with localized prostate cancer reach treatment decisions.

Authors:  Kathryn Birnie; John Robinson
Journal:  Can Fam Physician       Date:  2010-02       Impact factor: 3.275

2.  To Share or Not to Share: Malaysian Healthcare Professionals' Views on Localized Prostate Cancer Treatment Decision Making Roles.

Authors:  Yew Kong Lee; Ping Yein Lee; Ai Theng Cheong; Chirk Jenn Ng; Khatijah Lim Abdullah; Teng Aik Ong; Azad Hassan Abdul Razack
Journal:  PLoS One       Date:  2015-11-11       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.